Ergoteles LLC Ocular Therapeutix, Inc Transaction History

Ergoteles LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$2.79 - $6.27 $120,056 - $269,804	-43,031 Reduced 68.11%	20,145 $106,000
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $146,392 - $247,352	-56,089 Reduced 47.03%	63,176 $177,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $487,793 - $775,222	119,265 New	119,265 $495,000
Q2 2022 Aug 12, 2022	SELL	$3.01 - $5.22 $51,004 - $88,452	-16,945 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.83 - $7.35 $118,798 - $180,780	-24,596 Reduced 59.21%	16,945 $84,000

Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $33,473 - $65,588	5,434 Added 15.05%	41,541 $290,000
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $350,237 - $517,774	36,107 New	36,107 $361,000
Q2 2021 Aug 12, 2021	SELL	$13.43 - $19.16 $694,680 - $991,070	-51,726 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$15.82 - $22.11 $818,305 - $1.14 Million	51,726 New	51,726 $849,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.